BSEBoard Meeting2 Sept 2026 · 2 Sept 2026, 06:38 pm

Outcome of Board Meeting held on 02nd September 2026

Kabra Drugs Ltd · 524322

✦ AI SummaryResults

The Board of Directors of Kabra Drugs Ltd held a meeting on September 2, 2026, and considered and approved various items, including the Director's Report and Corporate Governance Report for the financial year ended March 31, 2026. The company also announced the re-appointment of Mr. Kuniamuthur Nanjappan Anand as Director, the appointment of M/s Karthik L & Associates as Internal Auditors, and the appointment of Ms. Moonam Kapoor and Mrs. Twinkle Agarwal as Directors and Secretarial Auditor, respectively. The meeting also approved the Notice of the 37th Annual General Meeting, which will be held on September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026

Attachments (1)

📄

6a94c12e-aebd-47aa-a984-05fd834d1ba5.pdf

pdf

Download →
View document text
Date: 02nd September 2026 BSE Limited Phiroze Jeejeebhoy Towers 21st Floor, Dalal Street Mumbai – 400001 BSE Scrip Code: 524322 Sub: Outcome of Board Meeting held on 02 nd September 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e 02nd September 2026. 1. Considered & approved Director’s Report and Corporate Governance Report for the financial year ended 31st March 2026. 2. The Register of Members and Share Transfer Register of the Company will remain close from 24th September 2026 (Thursday) to 30th September 2026 (Wednesday) (both days inclusive). 3. The Cut-off date would be 23rd September 2026 (Wednesday) and Book closure dates would be from 24th September 2026 (Thursday) to 30th September 2026 (Wednesday) (both days inclusive). 4. The E-voting Facility will start from 27th September 2026 (Sunday) at 09:00 AM and end on 29th September 2026 (Tuesday) at 05:00 PM (both days inclusive). 5. Approved Notice of the 37th Annual General Meeting of the members of the company, will be held at Chennai, 30th September 2026, Wednesday at 09:00 AM to transact the business as per the notice of 37th Annual General Meeting of the company. 6. Consider and approved appointment of Scrutinizer for Annual General Meeting (AGM) purpose. 7. Consider and Approved the re-appointment of Mr. Kuniamuthur Nanjappan Anand (DIN: 03230186), Director of the Company, who retires by rotation at the ensuing Annual General Meeting. 8. Consider and approved the appointment of M/s Karthik L & Associates, Chartered Accountants (FRN: 024924S) as Internal Auditors for the financial year 2026-2027 of the Company. 9. Consider and approved the appointment of Ms. Moonam Kapoor (DIN: 09278005) as Director of the Company. 10. Consider and approved the appointment of Mrs. Twinkle Agarwal, Practicing Company as the Secretarial Auditor of the Company for a period of five financial years commencing from the financial year 2026-2027 to 2030-2031. The meeting of the Board of Directors of the Company commenced at 05.00 p.m. (IST) and concluded at 06:30 p.m. (IST). Kindly take the aforesaid information on record and oblige. Thanking you, Yours sincerely, For Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) Nanjappan Aravind Managing Director DIN: 01895602